Answers are grounded in this paper and cite their sources.
Glucagon-like peptide-1 (GLP-1) receptor agonists became the most prescribed drugs for weight loss.This study aimed to investigate adverse events of GLP-1 receptor agonists using Twitter and KIDS-KAERS database (KIDS-KD).116 Korean tweets on Twitter and 1,701 liraglutide-adverse event combinations from KIDS-KD were used for analysis.The most common adverse events were nausea (37.76%), vomiting (12.59%), dyspepsia (9.79%), dizziness (4.90%), and somnolence (4.90%) on Twitter.Adverse events observed in the post-marketing surveillance such as somnolence, myalgia, chest pain/ discomfort, and parosmia were found on Twitter.In KIDS-KD, injection site rash (13.46%), injection site pruritus (10.76%), nausea (10.64%), vomiting (6.41%), and injection site reaction (5.29%) were commonly reported.Signals were injection site rash (reporting odds ratio [ROR] = 616.1),injection site pruritus (ROR = 477.7),vomiting (ROR = 2.4), injection site reaction (ROR = 222.0),pruritus (ROR = 2.5), injection site bruising (ROR = 45.8),injection site pain (ROR = 36.3).Subgroup analysis revealed that injection site rash (n = 16, ROR = 46.6)and acne (n = 3, ROR = 39.2) met signal criteria in men and women, respectively.Twitter analysis identified adverse events that were not found in clinical trials, and KIDS-KD subgroup analysis suggested the possibility of acne being a safety signal.Social media and KIDS-KD were useful for pharmacovigilance.
No takes yet. Share an insight, caveat, or question.
Back et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: